Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

This review examines its erectile dysfunction (ED) services, looking closely at what Hims offers its users, comparing its prices, researching how long it takes for Hims ED medications to work ...

It has expanded its offerings to include weight loss, focusing on prescription medications, including its own compounded semaglutide ... But some recent Hims and Hers reviews complain about ...

Telehealth company Hims & Hers Health (HIMS ... it will stop offering compounded semaglutide on its platform after the first quarter, triggering mixed reviews from analysts about the future ...

as unapproved versions do not undergo FDA’s review for safety, effectiveness and quality before they are marketed.” Back in May, Hims & Hers started selling compounded semaglutide — the ...

Hims & Hers turned in tremendous revenue and profitability growth in the fourth quarter. The company also issued very robust guidance. However, it will stop selling semaglutide-based weight-loss ...

Direct-to-consumer telehealth company Hims & Hers is forging ahead in the aftermath of the semaglutide shortage ending last week. Hims & Hers faces new headwinds in its weight management segment ...

Hims & Hers sells compounded semaglutide, a version of the active ingredient in Novo Nordisk’s Wegovy and Ozempic drugs. (Hims & Hers Health) Telehealth provider Hims & Hers Health is defending ...

It is the second big stock drop for Hims & Hers in a matter of days. The shares tumbled 26% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide ...

FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...

However, the stock gave back a lot of gains after semaglutide, the active ingredient in GLP-1 weight loss drug Ozempic, was taken off the Food & Drug Administration's shortage list. Hims & Hers ...